In this review, we summarise the evidence for neutrophilic inflammation in CF lung disease in order to address whether neutrophilic inflammation and high, uncontrolled NSP levels play a similar role in CF lung disease in the era of CFTR modulator therapy. This evidence concerns the gene CFTR and lung disorder.